June 10, 2002
Volume 80, Number 23
CENEAR 80 23 pp. 43-50
ISSN 0009-2347

[Back To Story]

STEADY RISE
Worldwide sales of single-enantiomer drugs approach $150 billion

2000 SINGLE-ENANTIOMER 2001a SINGLE-ENANTIOMER
$ BILLIONS TOTAL MARKET SALES MARKET SHARE TOTAL MARKET SALES MARKET SHARE
Antibiotics/antifungals $31.7 $25.9 82% $33.0 $26.9 82%
Hematology 15.4 12.0 78 16.5 13.5 82
Cancer 15.6 12.2 78 17.0 13.3 78
Hormones/endocrinology 22.0 15.2 69 26.0 18.5 71
Cardiovascular 46.6 27.7 59 50.0 30.2 60
Vaccines 7.3 3.4 47 8.5 4.3 51
Antivirals 19.1 5.9 31 20.0 6.1 31
Ophthalmic 7.4 2.3 31 8.0 2.4 30
Central nervous system 53.9 9.3 17 55.0 10.5 19
Respiratory 40.5 6.5 16 42.0 7.9 19
Gastrointestinal 47.2 4.2 9 50.0 5.4 11
Dermatology 18.4 1.3 7 18.5 1.2 6
Analgesics 23.0 1.2 5 23.5 1.2 5
Others 41.9 5.9 14 42.0 5.8 14
TOTAL $390.0 $133.0 34% $410.0 $147.2 36%
a Preliminary estimates. SOURCE: Technology Catalysts International

[Back To Story]



Top


Chemical & Engineering News
Copyright © 2002 American Chemical Society